Leigh Tesar Charged in DOJ 2026 Health Care Fraud Takedown Over Medicare Kickbacks

Indictment from the United States Attorney’s Office in the Middle District of Florida alleges a pay-for-patient referral scheme that steered Medicare beneficiaries toward costly wound allografts while purported marketers received compensation tied to products and referrals.

WASHINGTON, DC — Federal prosecutors placed Sarasota nurse practitioner Leigh Tesar at the center of a sprawling wound-care prosecution announced during the Justice Department’s 2026 National Health Care Fraud Takedown, alleging that patient referrals, expensive allografts, and Medicare billing became components of a coordinated kickback arrangement.

The case alleges that Tesar worked with Florida registered nurses Walter Presha Junior and Koby Evans to identify Medicare beneficiaries with wounds, purchase costly skin-substitute products, generate federal reimbursement claims, and distribute compensation through business relationships prosecutors characterize as disguises for patient referrals.

According to the Middle District of Florida’s official takedown announcement, the alleged operation generated more than $118 million in Medicare claims during approximately eighteen months, produced roughly $61 million in payments, and prompted authorities to seize approximately $11.8 million in connected assets.

Those figures make the Tesar prosecution one of the most closely watched wound-care cases within the national enforcement action, yet the indictment remains an accusation rather than a judgment, and every defendant retains the presumption of innocence unless prosecutors establish guilt beyond a reasonable doubt.

A Ten-Count Indictment Built Around Referrals

The grand jury returned ten counts on June 17, 2026, charging Tesar with five substantive health-care fraud offenses, one conspiracy offense, and two alleged kickback-payment offenses, while Presha and Evans face the conspiracy count and separate counts accusing each nurse of receiving prohibited remuneration.

Prosecutors describe Tesar as a licensed nurse practitioner who enrolled individually with Medicare and later reassigned her benefits to Tesar Primecare LLC, a Sarasota practice registered with the federal program as a single-specialty or multispecialty clinic or group practice.

Presha, identified in the indictment as a Manatee County registered nurse, owned Universal Nursing and Wellness LLC and operated W P Enterprises, while Evans, a Hillsborough County registered nurse, owned Healing His Way LLC and maintained a business account used in one disputed transaction.

An unnamed Pennsylvania business, identified only as Company-I, allegedly marketed and sold wound-care products to Tesar and Primecare while engaging Presha, Evans, and others as purported sales representatives through agreements prosecutors say concealed their real function as sources of Medicare patient referrals.

That distinction is central to the government’s theory because a legitimate sales representative may be paid for bona fide marketing work, whereas federal law restricts remuneration offered, paid, solicited, or received to induce referrals involving items or services reimbursed by Medicare.

How Prosecutors Say the Referral Pipeline Worked

The indictment alleges that Presha and Evans located Medicare beneficiaries with wounds and directed them toward Tesar, after which Prime Care purchased allografts from Company-I, applied or purportedly applied those products, and submitted high-value claims through the federal reimbursement system.

Prosecutors contend that Company-I then paid the purported representatives amounts connected to product purchases and patient assignments, allowing the alleged participants to describe the money as sales compensation even though the government says the underlying exchange concerned federally insured referrals.

The alleged arrangement therefore joined three financial steps that investigators frequently examine separately: acquiring a beneficiary, selecting a reimbursable product, and returning part of the resulting revenue stream to the person credited with bringing the patient into the treatment pipeline.

When those steps become economically dependent upon one another, prosecutors can argue that clinical demand was manufactured by compensation rather than discovered through independent medical judgment, while defense lawyers can challenge whether payments reflected lawful services, legitimate commissions, or misunderstood business arrangements.

The indictment further alleges that Tesar offered inducements to other health-care providers and individuals who could deliver Medicare beneficiaries, broadening the government’s theory beyond the two named nurses and suggesting that referral generation was an operating priority rather than an incidental feature.

Texts Allegedly Connected Patients, Prices, and Percentages

One message cited by prosecutors allegedly showed Tesar discussing movement from room to room while looking for wounds, followed by an acknowledgment that the approach might be unlawful, language the government may use to establish awareness and intent if admitted into evidence.

A September 2024 exchange allegedly identified more than $4.06 million in total invoices and calculated twenty percent as $813,925, giving prosecutors a numerical bridge between product invoices and compensation they characterize as payment for referrals.

In January 2025, Tesar allegedly introduced Evans to an owner of Company-I by stating that Evans had several patients ready to begin treatment, an exchange prosecutors may present as evidence that the purported sales role depended upon delivering beneficiaries rather than promoting products generally.

Later messages allegedly compared a product costing $2,000 per square centimeter with another costing $1,591, explained that a twenty-percent return would rise with the more expensive product, and described an intention to switch patients toward the higher-cost option.

An April 2025 exchange allegedly warned Evans not to disclose that Tesar had discussed money with the representatives, wording prosecutors interpret as concealment, although defense counsel may contest context, authorship, meaning, completeness, and the government’s characterization of every electronic communication.

Two Transfers Anchor the Kickback Counts

Counts seven and eight accuse Tesar of causing Company-I to make two payments on August 15, 2025, including approximately $397,570 deposited into Presha’s W P Enterprises account and approximately $10,998 deposited into Evans’s Healing His Way account.

Counts nine and ten mirror those allegations from the recipients’ side, accusing Presha and Evans of knowingly receiving the respective transfers in return for referring Medicare beneficiaries for wound-care products and services payable through a federal health-care program.

By charging both the alleged payment and receipt of remuneration, prosecutors have created paired counts focused on the same transactions, while the conspiracy count addresses the broader alleged agreement operating from approximately May 2024 through November 2025.

The government must still prove the required mental state for each defendant, including that disputed remuneration was knowingly and willfully connected to prohibited referrals, because a payment’s size, timing, or business label does not independently establish every element of a criminal offense.

Bank records, supplier ledgers, patient assignments, emails, texts, invoice calculations, and testimony from participants could collectively show whether the transfers followed legitimate sales activity or a concealed referral formula, making financial tracing an essential evidentiary component of the case.

Why the Anti-Kickback Rules Matter to Medicare

Medicare depends upon providers to recommend treatment according to patient need rather than undisclosed financial influence, because beneficiaries often cannot independently evaluate whether a particular wound product, treatment frequency, or referral relationship reflects sound medicine or a provider’s private compensation.

A kickback can distort decisions at several points by encouraging a marketer to find patients, rewarding a practitioner for choosing a high-priced product, discouraging less expensive conservative care, and creating financial pressure to continue applications even when measurable improvement is limited.

The indictment says Medicare would not reimburse products or services procured through illegal kickbacks, meaning the alleged referral payments could affect claim eligibility even when a product was physically delivered and a patient genuinely had a wound requiring professional attention.

That principle distinguishes the prosecution from a narrow dispute over whether individual grafts were clinically appropriate, because prosecutors allege that the financial origin of certain referrals independently contaminated claims submitted through a program conditioned upon compliance with federal law.

Health-care organizations therefore examine both clinical documentation and commercial relationships, since a technically accurate treatment note cannot neutralize a prohibited payment arrangement, while an unusual commission does not automatically prove that every associated medical service lacked therapeutic value.

Patients Allegedly Received Gifts and Waived Copayments

Prosecutors allege that Medicare beneficiaries were encouraged to begin or continue expensive allograft treatment through misrepresented costs, improperly waived copayments, free medical supplies, and valuable gifts that reportedly included jewelry and a leather recliner.

Beneficiary cost-sharing can be burdensome, but routine or selective waivers tied to treatment recruitment may remove a patient’s incentive to question necessity, price, or duration, while expensive gifts can transform consent into another compensated link within a referral structure.

The allegations are especially serious because wound-care patients may be elderly, disabled, chronically ill, homebound, or terminally ill, leaving them dependent upon licensed professionals for clear explanations about expected healing, treatment alternatives, personal obligations, and realistic clinical outcomes.

Even when Medicare bears most of the financial loss, an unnecessary application can expose a beneficiary to discomfort, infection risk, disrupted hospice priorities, repeated visits, confusing paperwork, and pressure to continue treatment that offers little reasonable prospect of improvement.

No beneficiary identified by initials in the indictment should be publicly blamed for the alleged scheme, because prosecutors portray patients as targets of inducements and disputed medical decisions rather than architects responsible for the commercial arrangements surrounding their care.

Expensive Allografts Became the Alleged Revenue Engine

The products involved include bioengineered skin substitutes and certain amniotic membrane allografts made from human placental tissue, which can assist wound closure or skin growth when used for appropriate patients under documented conditions meeting Medicare coverage requirements.

Medicare’s Florida contractor required continuing wound care to be supported by records showing improvement, accepted treatment standards, attention to conditions affecting healing, and a treatment duration reasonably connected to the patient’s expected capacity for restoration.

For qualifying diabetic foot ulcers and venous leg ulcers, the cited coverage rules generally required at least four weeks of completed and documented conservative care, including measures such as debridement, pressure relief, infection control, and management of wound drainage.

The indictment alleges that Tesar sometimes applied products without attempting or confirming conservative care, used them on infected wounds, continued after earlier applications failed, treated wounds unlikely to heal in terminal patients, and selected particular allografts primarily to maximize profit.

Those accusations place product choice at the intersection of medicine and reimbursement, because billing by surface area can make a larger or more expensive graft extraordinarily valuable while also creating incentives for repeated applications, product switching, or inflated treatment intensity.

Medical Records and Unperformed Services Under Scrutiny

Prosecutors allege that Tesar and others falsified records to make applications appear reasonable, necessary, and compliant, including by documenting treatments that did not occur, attributing earlier conservative care to Tesar, backdating wound documentation, and misstating patient conditions.

The indictment separately claims that Medicare received bills for graft applications that were never rendered, an allegation that moves beyond disputed clinical judgment and asserts that federal reimbursement was requested for treatment prosecutors say patients never received.

Investigators can compare claim dates with clinical notes, supplier shipments, inventory records, facility access logs, photographs, patient testimony, electronic messages, and bank activity, creating a detailed chronology that may confirm or undermine the government’s account for each beneficiary.

Defense counsel can nevertheless examine whether records were completed by delegated staff, copied through electronic templates, affected by coding errors, changed for legitimate reasons, or interpreted without clinical context, because negligent documentation and intentional falsification carry profoundly different criminal implications.

The government also alleges that Tesar removed her name as Prime Care’s owner from Florida corporate records after a Medicare audit while continuing to exercise ownership and managerial control, a step prosecutors characterize as an effort to evade further scrutiny.

Five Claims Give Jurors Patient-Level Examples

Counts one through five identify representative claims involving five beneficiaries whose initials protect their medical privacy, with alleged service dates between October 2024 and August 2025 and claimed amounts ranging from approximately $288,350 to more than $1.11 million.

Together, those five examples represent approximately $3.96 million billed and approximately $2.82 million paid, allowing prosecutors to present detailed treatment episodes inside a much larger narrative involving more than $118 million in submissions across the alleged operation.

For each substantive fraud count, the government alleges that products and services were falsely represented as medically necessary, eligible for reimbursement, delivered as described, and free from prohibited kickbacks, while Tesar may challenge every factual and legal component.

Patient-level evidence matters because a dramatic aggregate number can establish scale without proving intent, whereas records surrounding a specific wound, product order, invoice, application, and reimbursement can help jurors evaluate whether an individual claim knowingly executed an alleged fraudulent plan.

The defense may respond with clinical experts, alternative readings of coverage guidance, proof of services, or evidence that reimbursement professionals handled submissions, while prosecutors will likely emphasize repeated patterns and communications they say connect medical decisions with financial incentives.

$61 Million Paid and $11.8 Million Seized

Across the approximately eighteen-month period, prosecutors say Tesar and others submitted more than $118 million in false or ineligible Medicare claims, causing the program to pay Tesar and Prime Care more than $61 million for wound products and associated services.

The difference between billed and paid amounts reflects ordinary reimbursement adjustments, denials, or reductions, yet attempted claims can remain relevant to a fraud prosecution even when the program does not release every dollar initially requested by a provider.

The indictment’s forfeiture allegations attribute approximately $61.63 million in alleged proceeds to Tesar, approximately $3.19 million to Presha, and approximately $263,223 to Evans, while seeking directly traceable assets or substitute property if specified proceeds cannot be recovered.

Authorities identified seizures totaling approximately $11.8 million from bank and investment accounts connected with the matter, although forfeiture allegations remain contested and third parties may assert legitimate interests before a court determines whether particular property is criminally traceable.

Prosecutors further allege that proceeds supported lavish purchases, including more than $215,000 spent on Tampa Bay Buccaneers tickets and a luxury suite at Raymond James Stadium, together with more than $400,000 spent on fine art.

Luxury spending can make an indictment memorable, but expensive purchases are not independent proof of fraud, requiring the government to establish both the criminal source of disputed funds and the knowledge necessary for conviction under the charged statutes.

Part of the 2026 National Takedown

The Tesar indictment was announced as part of a coordinated enforcement action involving charges against 455 defendants, including 90 physicians and other licensed medical professionals, across 56 federal districts and 45 states and territories, according to federal officials.

The Justice Department said the cases collectively concerned more than $6.5 billion in alleged false claims, while authorities seized over $182 million in cash, residences, vehicles, jewelry, and other property through an operation emphasizing federal, state, and international coordination.

Independent reporting from WUSF and Health News Florida described Tesar’s case as one of the takedown’s largest alleged schemes and situated it among Florida prosecutions involving clinics, laboratory testing, medical equipment, telemedicine, and other reimbursable services.

The national scope demonstrates how investigators increasingly treat Medicare fraud as a networked market involving practitioners, marketers, suppliers, owners, billers, data brokers, and financial intermediaries rather than isolated misconduct confined to one examination room or billing office.

Wound-care cases received particular attention because expensive products can produce exceptionally large reimbursements from relatively few beneficiaries, allowing comparative claims analysis to reveal sudden billing growth, repeated applications, shared referral sources, and unusual product preferences.

Data Analytics Meet Traditional Evidence

Federal authorities highlighted data analytics as a defining feature of the 2026 takedown, using claims information to identify extreme billing, compare practitioners with peers, connect beneficiaries across providers, and locate networks that may otherwise appear as unrelated local businesses.

Algorithms can flag anomalies, but prosecutors ordinarily need conventional evidence to explain them, including witness accounts, communications, medical records, contracts, bank transfers, ownership filings, supplier documents, and expert testimony addressing both reimbursement requirements and clinical appropriateness.

In the Tesar matter, the alleged twenty-percent calculations, product-price comparisons, patient introductions, and same-day transfers provide prosecutors with a narrative connecting financial data to human decisions, while the defense can dispute whether those fragments accurately describe complete commercial relationships.

Audits can also become pivotal because they show what a provider knew after concerns were raised, whether questioned practices changed, who controlled the company, and how documents or ownership records evolved once Medicare began examining unusual claims.

For compliant providers, the enforcement lesson is practical: rapid revenue growth should trigger independent review of referral compensation, medical necessity, product selection, copayment practices, inventory reconciliation, documentation accuracy, and the actual delivery of every billed service.

What Providers Should Examine Now

Wound-care organizations should require written agreements describing genuine services, compensation supported by fair-market analysis, separation between referral activity and product commissions, documented conflict reviews, and continuing oversight that tests whether contractors perform the work they claim.

Clinical controls should independently confirm prior conservative treatment, infection status, wound measurements, healing progress, product choice, application frequency, and expected restoration potential, rather than allowing reimbursement targets or vendor relationships to determine a patient’s treatment plan.

Financial teams should reconcile every product purchase with a specific beneficiary, treatment record, application date, invoice, payment, and unused inventory amount, because gaps among those records can reveal billing errors, diversion, phantom services, or products selected mainly for margin.

Organizations should also preserve confidential reporting channels for nurses, patients, billers, and vendors, since employees who notice gifts, percentage-based payments, unexplained record changes, or repeated treatment failures may provide the earliest warning that ordinary operations have become legally dangerous.

When an investigation becomes public, accurate crisis PR management should coordinate closely with legal counsel, distinguish allegations from established facts, preserve patient confidentiality, and avoid speculative statements that could prejudice proceedings, mislead stakeholders, or create additional reputational damage.

An Indictment Is Not a Conviction

A federal indictment means a grand jury found probable cause to authorize charges, but it does not prove that Tesar, Presha, or Evans committed fraud, knowingly participated in a kickback agreement, falsified records, or understood the payments as prosecutors describe them.

At trial, the government would carry the burden of proving each charged element beyond a reasonable doubt, while the defendants could challenge searches, account tracing, witness credibility, electronic evidence, expert opinions, medical judgments, billing interpretations, and alleged conspiratorial intent.

The named defendants are entitled to counsel, pretrial discovery, evidentiary motions, confrontation of witnesses, and a fair adjudication, while responsible coverage must continue using allegation language unless a plea, verdict, dismissal, or judicial finding changes the public record.

Because online reports can remain prominent for years, any lawful reputation rebuilding strategy should rely upon truthful documentation and verified procedural developments, recognizing that acquittals, dismissals, convictions, restitution, cooperation, or other outcomes may substantially alter the responsible narrative.

Neither public relations work nor search optimization should be used to erase accurate reporting, intimidate witnesses, manipulate evidence, or obstruct justice, because ethical reputation management depends upon verifiable facts, lawful advocacy, transparency about unresolved allegations, and respect for judicial proceedings.

What Happens Next in the Leigh Tesar Case

The prosecution will move through discovery, expert review, motion practice, and possible trial preparation in the Middle District of Florida, where medical evidence and financial records may determine whether prosecutors can connect specific claims to the alleged referral-payment structure.

Forfeiture proceedings may develop alongside the criminal case, requiring courts to examine whether seized funds constitute traceable proceeds, whether substitute assets are available, and whether innocent third parties hold legitimate interests in any property sought by the government.

Medicare contractors, licensing boards, insurers, and health-care organizations may conduct separate reviews under different standards, meaning professional, administrative, or civil consequences can proceed independently of the criminal case and its heightened burden required for a conviction.

The case will ultimately turn upon evidence rather than the indictment’s scale, including whether treatments occurred, whether they were medically justified, whether records were knowingly falsified, and whether payments were intentionally exchanged for Medicare beneficiary referrals.

Until a court resolves those questions, the most accurate conclusion remains carefully balanced: prosecutors have described an unusually large and detailed alleged Medicare kickback operation, while Tesar, Presha, and Evans remain legally innocent unless and until proven guilty beyond a reasonable doubt.